We are live on
!
Find out more
PAM
PVG Asset Management Portfolio holdings
AUM
$173M
1-Year Est. Return
64.51%
This Fund
S&P 500
This Quarter
Est. Return
-1.45%
1 Year Est. Return
+64.51%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$23M
AUM Growth
+$1.84M
(+8.7%)
Cap. Flow
+$2.37M
Cap. Flow
% of AUM
10.33%
Top 10 Holdings %
Top 10 Hldgs %
60.56%
Holding
59
New
13
Increased
12
Reduced
18
Closed
13
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Direxion Daily S&P 500 Bear 1X ETF
SPDN
|
+$3.89M |
| 2 |
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$2.62M |
| 3 |
JPMorgan Equity Premium Income ETF
JEPI
|
+$359K |
| 4 |
Veru
VERU
|
+$341K |
| 5 |
GAP
The Gap Inc
GAP
|
+$293K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BXMX
Nuveen S&P 500 Buy-Write Income Fund
BXMX
|
+$1.28M |
| 2 |
ProShares Short S&P500
SH
|
+$1.05M |
| 3 |
ProShares UltraShort S&P500
SDS
|
+$501K |
| 4 |
Pfizer
PFE
|
+$360K |
| 5 |
AVDL
Avadel Pharmaceuticals
AVDL
|
+$358K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.96% |
| 2 | Technology | 9.17% |
| 3 | Consumer Discretionary | 4.62% |
| 4 | Consumer Staples | 3.54% |
| 5 | Real Estate | 2.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Direxion Daily S&P 500 Bear 1X ETF
SPDN
$226M
| $4.08M | 17.75% |
+351,871
| New | +$3.89M |
|
|
2
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$47.1B
| $3.18M | 13.82% |
34,618
+28,636
| +479% | +$2.62M |
|
3
Vanguard S&P 500 ETF
VOO
$956B
| $1.14M | 4.97% |
2,224
-2
| -0.1% | -$1.08K |
|
4
Journey Medical
DERM
$169M
| $1.03M | 4.48% |
174,379
+6,274
| +4% | +$30.8K |
|
5
iShares Core S&P 500 ETF
IVV
$858B
| $911K | 3.97% |
1,622
-66
| -4% | -$39K |
|
6
Amazon
AMZN
$2.44T
| $792K | 3.45% |
4,164
+778
| +23% | +$169K |
|
|
7
Veru
VERU
$35.5M
| $783K | 3.41% |
159,690
+54,959
| +52% | +$341K |
|
8
Fortress Biotech
FBIO
$111M
| $737K | 3.21% |
472,221
+85,926
| +22% | +$151K |
|
9
Anavex Life Sciences
AVXL
$231M
| $709K | 3.09% |
82,608
+4,118
| +5% | +$38.9K |
|
10
Apple
AAPL
$4.97T
| $557K | 2.42% |
2,506
-179
| -7% | -$41.5K |
|
11
NVIDIA
NVDA
$4.6T
| $545K | 2.37% |
5,024
-1,183
| -19% | -$150K |
|
12
Microsoft
MSFT
$2.9T
| $493K | 2.14% |
1,312
+26
| +2% | +$10.6K |
|
13
AbbVie
ABBV
$465B
| $480K | 2.09% |
2,291
-100
| -4% | -$19.4K |
|
14
Alphabet (Google) Class C
GOOG
$4.11T
| $437K | 1.9% |
2,799
+772
| +38% | +$141K |
|
|
CRDL
15
Cardiol Therapeutics
CRDL
$133M
| $424K | 1.85% |
437,362
-49,933
| -10% | -$61.3K |
|
|
FTHY
16
First Trust High Yield Opportunities 2027 Term Fund
FTHY
$499M
| $398K | 1.73% |
27,515
+745
| +3% | +$10.8K |
|
|
DX
17
Dynex Capital
DX
$3.17B
| $371K | 1.62% |
28,500
-10,996
| -28% | -$147K |
|
18
ExxonMobil
XOM
$650B
| $367K | 1.6% |
3,089
| – | – |
|
|
19
JPMorgan Equity Premium Income ETF
JEPI
$45.5B
| $352K | 1.53% |
+6,160
| New | +$359K |
|
|
GRAL
20
GRAIL Inc
GRAL
$2.72B
| $338K | 1.47% |
13,248
-9,039
| -41% | -$279K |
|
|
AXON
21
Axon Enterprise
AXON
$42.8B
| $321K | 1.4% |
610
-40
| -6% | -$23.4K |
|
|
22
Pfizer
PFE
$143B
| $295K | 1.28% |
11,634
-13,745
| -54% | -$360K |
|
23
PepsiCo
PEP
$196B
| $294K | 1.28% |
1,961
-121
| -6% | -$18K |
|
24
Corning
GLW
$107B
| $293K | 1.28% |
6,400
-100
| -2% | -$4.94K |
|
|
GAP
25
The Gap Inc
GAP
$7.3B
| $268K | 1.17% |
+13,009
| New | +$293K |
|
Similar funds
IAAG
CTEF
KIM
MC
GRA
VWWMG
RPSM
BAM
PVG Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, PVG Asset Management held 59 positions worth $23M, up 8.7% from $21.1M the previous quarter. Its ten largest holdings account for 61% of the portfolio.
PVG Asset Management deployed $2.37M of net new capital in Q1 2025, opening 13 new positions and adding to 12 existing holdings. Its largest new stake was Direxion Daily S&P 500 Bear 1X ETF: 351,871 shares worth $4.08M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Pfizer, an estimated $360K trimmed.
- PVG Asset Management's largest Q1 2025 buy was Direxion Daily S&P 500 Bear 1X ETF: 351,871 shares worth $4.08M.
- PVG Asset Management added most to State Street SPDR Bloomberg 1-3 Month T-Bill ETF in Q1 2025, an estimated $2.62M increase.
- PVG Asset Management's biggest Q1 2025 reduction was Pfizer, cutting an estimated $360K.
- PVG Asset Management fully exited Nuveen S&P 500 Buy-Write Income Fund in Q1 2025, selling an estimated $1.28M.
- PVG Asset Management's ten largest holdings make up 61% of its $23M portfolio in Q1 2025.
- PVG Asset Management opened 13 new positions and closed 13 in Q1 2025.
- PVG Asset Management's portfolio value rose 8.7% quarter-over-quarter to $23M.
Based on PVG Asset Management's 13F filing for Q1 2025, filed 4 Jun 2025.